There are 412 resources available
Welcome
Presenter: Sara Tolaney
Session: Pfizer - The path to strategic sequencing in 3L HER2+ metastatic breast cancer
Resources:
Webcast
Reading the chessboard: Transformation and opportunities in the treatment landscape of HER2+ MBC
Presenter: Sara Tolaney
Session: Pfizer - The path to strategic sequencing in 3L HER2+ metastatic breast cancer
Resources:
Webcast
CNS defence: A case-based conversation about the threat of CNS involvement and clinical decision-making in HER2+ MBC
Presenter: Rupert Bartsch
Session: Pfizer - The path to strategic sequencing in 3L HER2+ metastatic breast cancer
Resources:
Webcast
Moving forward: A case-based conversation on clinical decision-making in 3L post T-DXd progression and future directions in HER2+ MBC
Presenter: Carmen Criscitiello
Session: Pfizer - The path to strategic sequencing in 3L HER2+ metastatic breast cancer
Resources:
Webcast
Panel discussion and audience Q&A
Session: Pfizer - The path to strategic sequencing in 3L HER2+ metastatic breast cancer
Resources:
Webcast
Closing remarks
Presenter: Sara Tolaney
Session: Pfizer - The path to strategic sequencing in 3L HER2+ metastatic breast cancer
Resources:
Webcast
Opening session
Session: Welcome to the ESMO Breast Cancer 2024 and Keynote lecture 1
Resources:
Slides
Webcast
Introduction to Keynote lecture 1
Presenter: Masakazu Toi
Session: Welcome to the ESMO Breast Cancer 2024 and Keynote lecture 1
Resources:
Webcast
Making personalized precision medicine a reality for breast cancer in 2024
Presenter: Nadia Harbeck
Session: Welcome to the ESMO Breast Cancer 2024 and Keynote lecture 1
Resources:
Slides
Webcast
Secondary use of existing health data for real-world analyses
Presenter: Antonis Valachis
Session: Practice changes based on real-world data
Resources:
Slides
Webcast